Skip to main content
GENINCODE PLC logo

GENINCODE PLC — Investor Relations & Filings

Ticker · GENI ISIN · GB00BL97B504 LEI · 213800UX6TE7K65O2892 IL Professional, scientific and technical activities
Open in API
Filings indexed 111 across all filing types
Latest filing 2025-03-05 Major Shareholding Noti…
Country GB United Kingdom
Listing IL GENI

About GENINCODE PLC

https://genincode.com/

GENINCODE PLC specializes in the genetic risk assessment and prediction of cardiovascular disease (CVD). The company develops and commercializes clinical genetic tests that combine genomic data with clinical algorithms and artificial intelligence (AI). These advanced risk assessment tools provide physicians with a predictive analysis of a patient's health, enabling personalized prevention and treatment strategies for CVD. The company's technology is founded on over 15 years of research and development in cardiovascular genomics, aiming to improve patient outcomes by identifying at-risk individuals before the onset of disease.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number' and contains the standard format for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) by individuals or entities. This type of regulatory disclosure regarding shareholding changes fits best under the 'Major Shareholding Notification' category (MRQ). Although it is distributed via RNS, the specific content is a formal notification of a change in major holding, making MRQ the most precise classification over the general RNS fallback.
2025-03-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and is distributed via 'RNS Number'. This form is used to report changes in significant share ownership (crossing thresholds). This directly corresponds to the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the content is specific to a major holding change, making MRQ the most precise classification over the general RNS fallback.
2025-03-04 English
Result of General Meeting, Issue of Equity and TVR
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange. The title explicitly states 'Result of General Meeting, Issue of Equity and Total Voting Rights'. It details the results of shareholder votes (Resolution 1 and 2 passed) and confirms the total voting rights following a recent fundraising event (Placing, Subscription, Retail Offer). This content directly relates to the outcome of a shareholder meeting and subsequent capital changes, fitting the description of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it mentions the General Meeting, the primary focus is reporting the results of the votes and the resulting share count change, making DVA the most precise fit over AGM-R (which is for presentations/materials) or SHA (which is for the announcement of the capital change itself, though this document covers both the vote authorizing it and the resulting rights). Given the explicit reporting of vote results, DVA is selected.
2025-03-03 English
Result of Retail Offer
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the London Stock Exchange. The content details the 'Result of Retail Offer' following a previously announced fundraising (Placing and Subscription). It confirms the gross proceeds raised (£4.1 million) and the number of new Ordinary Shares allotted. This type of announcement, concerning capital raising results and subsequent share allotment/admission to trading, falls under financing activities. While it relates to capital, the primary function here is the formal announcement of the completion/result of a fundraising effort, which aligns best with the 'Capital/Financing Update' (CAP) category, as it is a direct update on the company's financing activities. It is not a general regulatory filing (RNS) because it is highly specific to a financing event, nor is it a general earnings release (ER) or a formal report (10-K, IR).
2025-02-18 English
Result of Placing and Subscription
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 1948X) on 14 February 2025. The content explicitly details the 'Result of Placing and Subscription,' announcing that the company has conditionally raised gross proceeds of £4.0 million through the issue of New Ordinary Shares. It discusses the Issue Price, director subscriptions, and conditions related to a General Meeting and Admission to AIM. This is a specific announcement regarding a capital-raising/financing activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP). Although it is an RNS announcement, the specific content is highly focused on capital raising, making CAP more precise than the general RNS fallback.
2025-02-14 English
Retail Offer
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 1040X') dated February 14, 2025. The content explicitly details a 'conditional retail offer of new Ordinary Shares' at a specific 'Issue Price' (3.7 pence) and mentions a related 'Placing' and 'Subscription' as part of a larger 'Fundraising'. This announcement is focused on the mechanics and terms of issuing new capital/shares to raise funds, including details on pricing, minimum subscription, and closing dates. This directly aligns with the definition of 'Capital/Financing Update' (Code: CAP), as it announces the terms of a share issuance to raise capital. While it involves shares, it is primarily about the financing event rather than a general share repurchase (POS) or a general share issue announcement without the context of fundraising (SHA). It is not an ER (only highlights), 10-K (annual report), or IR (interim report). It is a specific announcement about raising capital through share issuance.
2025-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.